CDK9 inhibitor(1415559-43-1)
- Name: CDK9 inhibitor
- Synonyms:N-(5-(6-(3-(1,3-dioxoisoindolin-2-yl)phenyl)pyrimidin-4-ylamino)-2-methylphenyl)methanesulfonamide;
- Molecular Formula:C26H21N5O4S
- Molecular Weight:499.54104
- CAS Registry Number:1415559-43-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1415559-43-1 CDK9-IN-1
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.1415559-43-1 CDK9-IN-1
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal Chemistry Biomedicine Pharmaceutical intermediates Chemistry experiment Biological experiments Chemical reagent For R&D use only.
Min. Order:10Milligram
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)] CAS No.1415559-43-1 CDK9-IN-1
Assay:>98% Package:inquiry Transportation:inquiry Application:Among CDKs, CDK9 is a validated pathological target in HIV infection, inflammation and cardiac hypertrophy; however selective CDK9 inhibitors are still not available. We present a selective inhibi...
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 1370261-98-5/PRT062607 acetate
- 364762-86-7/TD-198946
- 1228237-47-5/Methanol, 1-[3-[5-[2-[[(3R)-1-[(1-methyl-1H-pyrazol-3-yl)sulfonyl]-3-piperidinyl]amino]-4-pyrimidinyl]imidazo[2,1-b]oxazol-6-yl]phenoxy]-, 1-(dihydrogen phosphate)
- 1186231-83-3/TAK-441
- 1194508-25-2/Edivoxetine
- 159857-81-5/L-Ornithinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-[[[(4-nitrophenoxy)carbonyl]oxy]methyl]phenyl]-
- 956590-23-1/UNBS-5162
- 855527-92-3/NBI-74330
- 1311423-89-8/Benzamide, N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[2-(dimethylamino)ethoxy]-6-ethoxy-
- 1319207-44-7/CC0651
- 406231-90-1/SZ4TA2
- 871266-63-6/PCI-27483
- 891499-69-7/CCR5 antagonist (hydrochloride)
- 308359-57-1/Zalypsis
- 882755-95-5/Phosphonic acid, [5-[2-amino-5-(2,2-dimethyl-1-oxopropyl)-4-thiazolyl]-2-furanyl]-
- 865854-05-3/4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione
- 1233948-61-2/EL-102
- 947257-66-1/D-3263
- 1148115-99-4/UR-63325
- 1415559-43-1/CDK9 inhibitor
- 1345675-02-6/ETP46464
- 847375-16-0/N-[[4-[(4,10-Dihydro-1-methylpyrazolo[3,4-b][1,5]benzodiazepin-5(1H)-yl)carbonyl]-2-methylphenyl]methyl]-4-[(3,5-dihydroxyphenyl)methyl]-1-piperazinecarboxamidedihydrochloride
- 1006037-11-1/Benzoic acid, 4-[1-[[[2,5-dimethyl-4-[[4-(trifluoromethyl)phenyl]methyl]-3-thienyl]carbonyl]amino]cyclopropyl]-, methyl ester
- 1006037-10-0/Benzoic acid, 4-(1-isocyanatocyclopropyl)-, methyl ester
- 1024120-52-2/1H-Pyrazole, 4-bromo-1-(1-ethoxyethyl)-
- 153653-30-6/Dofequidar fumarate
- 865783-99-9/Phenol, 2-methoxy-5-[[[(1E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl]methyl]-, 1-(dihydrogen phosphate)
- 473382-50-2/BenzeneMethanaMine, α,α-diMethyl-4-(3-phenyl-2-quinoxalinyl)-, Monohydrochloride (9CI)
- 2542-99-6/Pregn-20-yne-3,17-diol, (3α,5β,17α)-
- 928333-30-6/4-[6-[[(Furan-2-yl)methyl]amino]imidazo[1,2-b]pyridazin-3-yl]phenol